Inhibition of the 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) as a novel approach to type 2 diabetes treatment.

被引：0
|
作者：
Barf, T
Vallgårda, J
Kurz, G
Alberts, P
Abrahmsen, L
机构：
[1] Biovitrum, Dept Med Chem, SE-75137 Uppsala, Sweden
[2] Biovitrum, Dept Struct Chem, SE-75137 Uppsala, Sweden
[3] Biovitrum, Dept Biol, SE-75137 Uppsala, Sweden
[4] Biovitrum, Dept Assay Dev & Screening, SE-75137 Uppsala, Sweden
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 225卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
188-MEDI
引用
收藏
页码：U207 / U207
页数：1
相关论文
共 50 条
  • [1] 11-Beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors in Type 2 diabetes mellitus and obesity
    Hughes, Katherine A.
    Webster, Scott P.
    Walker, Brian R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (04) : 481 - 496
  • [2] Medicinal Chemistry of Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1)
    Scott, James S.
    Goldberg, Frederick W.
    Turnbull, Andrew V.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (11) : 4466 - 4486
  • [3] Inhibition of 11β-hydroxysteroid dehydrogenase type 1 (11 β-HSD1) by carbenoxolone (CBX) in obese Zucker rats
    Chatelain, R
    Odorico, L
    Schwarztkopf, C
    Battle, B
    Stevens, D
    Dardik, B
    Laurent, D
    Sun, DM
    Burkey, B
    Hughes, T
    DIABETES, 2003, 52 : A326 - A326
  • [4] Synthesis and optimization of arylsulfonylpiperazines as a novel class of inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)
    Sun, Daqing
    Wang, Zhulun
    Cardozo, Mario
    Choi, Rebekah
    DeGraffenreid, Michael
    Di, Yongmei
    He, Xiao
    Jaen, Juan C.
    Labelle, Marc
    Liu, Jinsong
    Ma, Ji
    Miao, Shichang
    Sudom, Athena
    Tang, Liang
    Tu, Hua
    Ursu, Stefania
    Walker, Nigel
    Yan, Xuelei
    Ye, Qiuping
    Powers, Jay P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (05) : 1522 - 1527
  • [5] Synthesis and optimization of picolinamide derivatives as a novel class of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors
    Ryu, Je Ho
    Kim, Shinae
    Lee, Jung A.
    Han, Hye Young
    Son, Hyun Joo
    Lee, Hyun Jung
    Kim, Yong Hyuk
    Kim, Jae-Sun
    Park, Hyeung-geun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (08) : 1679 - 1683
  • [6] Discovery and initial SAR of arylsulfonylpiperazine inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)
    Sun, Daqing
    Wang, Zhulun
    Di, Yongmei
    Jaen, Juan C.
    Labelle, Marc
    Ma, Ji
    Miao, Shichang
    Sudom, Athena
    Tang, Liang
    Tomooka, Craig S.
    Tu, Hua
    Ursu, Stefania
    Walker, Nigel
    Yan, Xuelei
    Ye, Qiuping
    Powers, Jay P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (12) : 3513 - 3516
  • [7] Atheroprotection Induced by Selective 11β-Hydroxysteroid Dehydrogenase Type 1 (11βHSD1) Inhibition in Male ApoE-/-Mice
    Huebschle, Thomas
    Falk, Eugen
    Glien, Maike
    Sadowski, Thorsten
    Ruetten, Hartmut
    DIABETES, 2011, 60 : A105 - A105
  • [8] 11β-hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension
    Campino, Carmen
    Carvajal, Cristian A.
    Cornejo, Javiera
    San Martin, Betty
    Olivieri, Oliviero
    Guidi, Giancesare
    Faccini, Giovanni
    Pasini, Francesco
    Sateler, Javiera
    Baudrand, Rene
    Mosso, Lorena
    Owen, Gareth I.
    Kalergis, Alexis M.
    Padilla, Oslando
    Fardella, Carlos E.
    ENDOCRINE, 2010, 37 (01) : 106 - 114
  • [9] 11β-hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension
    Carmen Campino
    Cristian A. Carvajal
    Javiera Cornejo
    Betty San Martín
    Oliviero Olivieri
    Giancesare Guidi
    Giovanni Faccini
    Francesco Pasini
    Javiera Sateler
    Rene Baudrand
    Lorena Mosso
    Gareth I. Owen
    Alexis M. Kalergis
    Oslando Padilla
    Carlos E. Fardella
    Endocrine, 2010, 37 : 106 - 114
  • [10] Development of 11β-HSD1 inhibitors for the treatment of type 2 diabetes
    Hale, Clarence
    Wang, Minghan
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (07) : 702 - 710
12345